Screener
Ionis Pharmaceuticals IONS Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Contracts receivable | 58,845 | 66,059 |
| Inventories | 50,833 | 10,048 |
| Other current assets | 327,011 | 237,092 |
| Total current assets | 2,491,274 | 2,990,635 |
| Property, plant and equipment, net | 155,131 | 123,048 |
| Right-of-use assets | 231,560 | 238,549 |
| Deposits and other assets | 116,536 | 171,604 |
| Total assets | $$2,994,501 | 3,523,836 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's total current assets?
- Ionis Pharmaceuticals (IONS) reported total current assets of $2.49B in Q2 2026.
- How has Ionis Pharmaceuticals's total current assets changed year-over-year?
- Ionis Pharmaceuticals's total current assets decreased by 3.3% year-over-year, from $2.58B to $2.49B.
- What is the long-term trend for Ionis Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's total current assets has grown at a 7.0% compound annual growth rate (CAGR), from $2.13B to $2.99B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Ionis Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude